Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma Meeting Abstract


Authors: Ku, G. Y.; Janjigian, Y. Y.; Shah, M. A.; Herrera, J.; Tang, L. H.; Fuqua, L.; Capanu, M.; Ilson, D.
Abstract Title: Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma
Meeting Title: 2013 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 4 Suppl.
Meeting Dates: 2013 Jan 24-26
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-02-01
Language: English
ACCESSION: WOS:000333679000093
DOI: 10.1200/jco.2013.31.4_suppl.91
PROVIDER: wos
Notes: Meeting Abstract: 91 -- Source: Wos
Altmetric Score
MSK Authors
  1. Geoffrey Yuyat Ku
    86 Ku
  2. Marinela Capanu
    206 Capanu
  3. Yelena Yuriy Janjigian
    145 Janjigian
  4. Manish Shah
    174 Shah
  5. Laura Hong Tang
    320 Tang
  6. David H Ilson
    269 Ilson